Figure 6.

Details about the potent epitopes and the design of multi-epitope vaccine construct. (A) Table showing the human leukocyte antigen (HLA) class I supergroup coverage of potent CD8+ T-cell epitopes. (B) Summary of the potent CD8+ T-cell, CD4+ T-cell, B-cell linear, and B-cell conformational epitopes used for the vaccine design. Note that if a potent epitope has already been reported elsewhere, it is highlighted in dark blue. (C) Linear multi-epitope vaccine construct designed using potent CD8+ T-cell, CD4+ T-cell, and B-cell epitopes predicted from ORF9b, N, and M/M.ext proteins. Note that ORF9b, N, and M/M.ext epitopes are depicted in pink, green, and blue, respectively.